Iambic Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-04-08. The offering totals $50.0M, of which $27.8M was reported sold. Industry: Biotechnology.
Showing 25 of 28 people.
| Name | Role | Location |
|---|---|---|
| Jishnu Bhattacharjee | Related Person | San Diego, CA |
| Neil Josephson | Related Person | San Diego, CA |
| Fred Manby | Related Person | San Diego, CA |
| Thomas Miller | Related Person | BALA CYNWYD, PA |
| Pete Olson | Related Person | San Diego, CA |
| Evan Rachlin | Related Person | San Diego, CA |
| William Rastetter | Related Person | San Diego, CA |
| Michael Secora | Related Person | San Diego, CA |
| Shalini Sharp | Related Person | San Diego, CA |
| Mary Tagliaferri | Related Person | San Diego, CA |
| R. Jacob Vogelstein | Related Person | Cambridge, MA |
| Kurt von Emster | Related Person | Redwood City, CA |
| Jishnu Bhattacharjee | Director | San Diego, CA |
| William Rastetter | Director | San Diego, CA |
| Fred Manby | Director | San Diego, CA |
| Fred Manby | Executive Officer | San Diego, CA |
| Shalini Sharp | Director | San Diego, CA |
| Neil Josephson | Executive Officer | San Diego, CA |
| Michael Secora | Executive Officer | San Diego, CA |
| R. Jacob Vogelstein | Director | Cambridge, MA |
| Mary Tagliaferri | Director | San Diego, CA |
| Evan Rachlin | Director | San Diego, CA |
| Thomas Miller | Director | BALA CYNWYD, PA |
| Thomas Miller | Executive Officer | BALA CYNWYD, PA |
| Pete Olson | Executive Officer | San Diego, CA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2025-11-21 | D | $125.0M | $99.3M |
| 2024-06-06 | D/A | $50.0M | $38.4M |
| 2024-05-07 | D/A | $38.0M | $29.9M |
| 2024-04-25 | D | $38.0M | $26.9M |
| 2023-10-12 | D | $110.0M | $103.2M |